progressive disease


Also found in: Acronyms.

progressive disease

Medspeak
Any chronic or dread disease (e.g., cancer), which progresses with time in scope and/or severity.

Oncology
A term defined in the context of clinical trials as tumour growth of ≥ 20% since treatment began, including local or metastatic tumour mass.

progressive disease

Medtalk A chronic or dread disease–eg, CA, which ↑ with time in scope or severity. See Dread disease.
References in periodicals archive ?
The medical community is left to decide the course of treatment for a progressive disease in which limited data exist.
The progressive disease is caused by a mutation in the x-linked DMD gene that encodes the protein dystrophin.
Another type of MS is primary progressive disease where symptoms get worse from the outset.
Cystic Fibrosis is a progressive disease with the average age of death for a person with CF of around 29 years old.
Hageman has spent his career exploring the concept that age-related macular degeneration is not a single progressive disease, but rather at least two diseases manifest by distinctly different biological pathways.
Multiple sclerosis (MS) is a chronic and progressive disease of the central nervous system (CNS), in which physical disability progresses over time.
Women with either relapsing (R-MS) or primary progressive disease (PPMS) who do not bear children are more likely to have higher disability scores than those who had at least one child.
They have found a fifth gene mutation they hope will help to find a cure for the progressive disease, which causes gradual muscle wasteandeating,speech and breathing problems.
HE4, a new biomarker for ovarian cancer from Fujirebio Diagnostics, Inc., is available in the United States for use as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer.
Unlike some of the previous studies of this procedure, this one involved people with relapsing-remitting disease, rather than people with later stage, progressive disease. In this uncontrolled trial, they found that the procedure was relatively safe, and after an average of 37 months, none of the 21 participants had progressed.
In a small study involving 23 patients, the vaccine increased survival time without progressive disease from 6.4 months to 16.6 months.
Every person living with or caretaking those with Multiple Sclerosis and any public or health library catering to patrons with MS needs this handbook, which focuses on the specific, special challenges of MS and how to handle daily life with a progressive disease. Chapters discuss the physical and psychological challenges of managing MS symptoms and progression, offering a range of insights and tips on treatments and options throughout.

Full browser ?